Literature DB >> 7696450

Polymeric nutrition as the primary therapy in children with small bowel Crohn's disease.

R M Beattie1, E J Schiffrin, A Donnet-Hughes, A C Huggett, P Domizio, T T MacDonald, J A Walker-Smith.   

Abstract

BACKGROUND: Recent studies in adults have shown that polymeric (whole protein) diets are as effective as semi-elemental and elemental formulae for the induction of remission in small bowel Crohn's disease. Whole protein diets are more palatable and cheaper. There have been no studies confirming efficacy in children. PATIENTS AND METHODS: We report our experience with seven children with active small bowel Crohn's disease given a casein-based, polymeric feed rich in TGF-beta 2 (Specific Polymeric Diet; Nestle-Clintec; Vevey, Switzerland) as complete nutrition for 8 weeks.
RESULTS: Initial and follow-up assessments were performed. All children showed a significant improvement in disease activity, with C-reactive protein returning to normal, an increase in serum albumin and a good weight gain. Initial and follow-up ileal biopsies were assessed and showed reduced mucosal inflammation in six of seven children, with complete healing in two.
CONCLUSION: In an uncontrolled descriptive study we have shown that a polymeric (whole protein) diet is a therapeutic option for small bowel Crohn's disease in children. By comprehensive follow-up we have demonstrated clinical and biochemical remission, with an improved endoscopic appearance and a reduction of mucosal inflammation in the terminal ileum.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7696450     DOI: 10.1111/j.1365-2036.1994.tb00338.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  20 in total

Review 1.  Chronic inflammatory bowel disease in children: a complex problem in management.

Authors:  J A Walker-Smith
Journal:  Postgrad Med J       Date:  2000-08       Impact factor: 2.401

Review 2.  Therapy of Crohn's disease in childhood.

Authors:  R M Beattie
Journal:  Paediatr Drugs       Date:  2000 May-Jun       Impact factor: 3.022

Review 3.  An update of the role of nutritional therapy in the management of Crohn's disease.

Authors:  Moftah H Alhagamhmad; Andrew S Day; Daniel A Lemberg; Steven T Leach
Journal:  J Gastroenterol       Date:  2012-06-15       Impact factor: 7.527

4.  Colonic Crohn's disease in children does not respond well to treatment with enteral nutrition if the ileum is not involved.

Authors:  Nadeem A Afzal; Sue Davies; Morine Paintin; Franck Arnaud-Battandier; John A Walker-Smith; Simon Murch; Robert Heuschkel; John Fell
Journal:  Dig Dis Sci       Date:  2005-08       Impact factor: 3.199

5.  European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis.

Authors:  E F Stange; S P L Travis; S Vermeire; C Beglinger; L Kupcinkas; K Geboes; A Barakauskiene; V Villanacci; A Von Herbay; B F Warren; C Gasche; H Tilg; Stefan W Schreiber; J Schölmerich; W Reinisch
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

6.  Does polymeric formula improve adherence to liquid diet therapy in children with active Crohn's disease?

Authors:  A F Rodrigues; T Johnson; P Davies; M S Murphy
Journal:  Arch Dis Child       Date:  2007-05-02       Impact factor: 3.791

Review 7.  Nutritional status and nutritional therapy in inflammatory bowel diseases.

Authors:  Corina Hartman; Rami Eliakim; Raanan Shamir
Journal:  World J Gastroenterol       Date:  2009-06-07       Impact factor: 5.742

8.  Treatment of orofacial and ileo-colonic Crohn's disease with total enteral nutrition.

Authors:  S Lim; R Dohil; N Meadows; P Domizio; I R Sanderson
Journal:  J R Soc Med       Date:  1998-09       Impact factor: 5.344

Review 9.  Nutritional management of Crohn's disease in childhood.

Authors:  R M Beattie
Journal:  J R Soc Med       Date:  1998-03       Impact factor: 5.344

Review 10.  Use of exclusive enteral nutrition in adults with Crohn's disease: a review.

Authors:  Catherine L Wall; Andrew S Day; Richard B Gearry
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.